Statin therapy for healthy men identified as "increased risk"

JAMA. 2012 Apr 11;307(14):1489-90. doi: 10.1001/jama.2012.425.

Authors

Michael J Blaha¹, Khurram Nasir, Roger S Blumenthal

Affiliation

¹ The Johns Hopkins Ciccarone Center for the Prevention of Heart Disease, 600 N Wolfe St, Baltimore, MD 21287, USA.

PMID: 22496260
DOI: 10.1001/jama.2012.425

No abstract available

MeSH terms

Blood Pressure
Cholesterol, HDL / blood
Cholesterol, LDL / blood
Coronary Artery Disease / epidemiology
Coronary Artery Disease / prevention & control*
Decision Making*
Diet
Evidence-Based Medicine
Exercise
Humans
Hydroxymethylglutaryl-CoA Reductase Inhibitors / adverse effects
Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use*
Hypercholesterolemia / drug therapy*
Life Style
Male
Middle Aged
Practice Guidelines as Topic
Randomized Controlled Trials as Topic
Risk

Substances

Cholesterol, HDL
Cholesterol, LDL
Hydroxymethylglutaryl-CoA Reductase Inhibitors